Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Otsuka Holdings Co ( (JP:4578) ).
Otsuka Holdings has approved a share repurchase program and subsequent cancellation of treasury stock as part of a broader effort to enhance capital efficiency and return profits to shareholders. The board resolution allows the company to buy back up to 7,000,000 common shares, equivalent to about 1.33 percent of shares outstanding excluding treasury stock, for a total outlay of up to ¥50 billion between February 16 and December 23, 2026.
All shares repurchased under this program will be cancelled on January 29, 2027, effectively reducing the company’s share count and potentially boosting per-share metrics for investors. The move underscores a shareholder-friendly capital allocation policy and may strengthen Otsuka’s market positioning by signaling confidence in its financial health and long-term value creation prospects.
The most recent analyst rating on (JP:4578) stock is a Buy with a Yen12600.00 price target. To see the full list of analyst forecasts on Otsuka Holdings Co stock, see the JP:4578 Stock Forecast page.
More about Otsuka Holdings Co
Otsuka Holdings Co., Ltd., listed on the Prime Market of the Tokyo Stock Exchange under code 4578, operates as a diversified healthcare group. The company is involved in pharmaceuticals and related businesses, focusing on delivering medical and health-related products and services to global markets and its shareholder base.
Average Trading Volume: 1,094,194
Technical Sentiment Signal: Buy
Current Market Cap: Yen5200.1B
Learn more about 4578 stock on TipRanks’ Stock Analysis page.